By integrating gene expression, epigenetic, immune, and survival data, this analysis underscores the central roles of CCL18 and EGF within the tumor ecosystem and highlights the value of network-based approaches in uncovering novel regulatory axes in cancer progression. This evidence concerns the gene CCL18 and cancer.